Patents by Inventor David Geraint Owen

David Geraint Owen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10006902
    Abstract: The present invention relates to a structure comprising a biological membrane and a porous or perforated substrate, a biological membrane, a substrate, a high throughput screen, methods for production of the structure membrane and substrate, and a method for screening a large number of test compounds in a short period. More particularly it relates to a structure comprising a biological membrane adhered to a porous or perforated substrate, a biological membrane capable of adhering with high resistance seals to a substrate such as perforated glass and the ability to form sheets having predominantly an ion channel or transporter of interest, a high throughput screen for determining the effect of test compounds on ion channel or transporter activity, methods for manufacture of the structure, membrane and substrate, and a method for monitoring ion channel or transporter activity in a membrane.
    Type: Grant
    Filed: June 23, 2014
    Date of Patent: June 26, 2018
    Assignee: SOPHION BIOSCIENCE A/S
    Inventors: David Geraint Owen, Nicholas Gerard Byrne
  • Publication number: 20160054298
    Abstract: The present invention relates to a structure comprising a biological membrane and a porous or perforated substrate, a biological membrane, a substrate, a high throughput screen, methods for production of the structure membrane and substrate, and a method for screening a large number of test compounds in a short period. More particularly it relates to a structure comprising a biological membrane adhered to a porous or perforated substrate, a biological membrane capable of adhering with high resistance seals to a substrate such as perforated glass and the ability to form sheets having predominantly an ion channel or transporter of interest, a high throughput screen for determining the effect of test compounds on ion channel or transporter activity, methods for manufacture of the structure, membrane and substrate, and a method for monitoring ion channel or transporter activity in a membrane.
    Type: Application
    Filed: June 23, 2014
    Publication date: February 25, 2016
    Inventors: David Geraint Owen, Nicholas Gerard Byrne
  • Publication number: 20150068925
    Abstract: The present invention relates to a structure comprising a biological membrane and a porous or perforated substrate, a biological membrane, a substrate, a high throughput screen, methods for production of the structure membrane and substrate, and a method for screening a large number of test compounds in a short period. More particularly it relates to a structure comprising a biological membrane adhered to a porous or perforated substrate, a biological membrane capable of adhering with high resistance seals to a substrate such as perforated glass and the ability to form sheets having predominantly an ion channel or transporter of interest, a high throughput screen for determining the effect of test compounds on ion channel or transporter activity, methods for manufacture of the structure, membrane and substrate, and a method for monitoring ion channel or transporter activity in a membrane.
    Type: Application
    Filed: June 23, 2014
    Publication date: March 12, 2015
    Inventors: David Geraint Owen, Nicholas Gerard Byrne
  • Patent number: 8759017
    Abstract: The present invention relates to a structure comprising a biological membrane and a porous or perforated substrate, a biological membrane, a substrate, a high throughput screen, methods for production of the structure membrane and substrate, and a method for screening a large number of test compounds in a short period. More particularly it relates to a structure comprising a biological membrane adhered to a porous or perforated substrate, a biological membrane capable of adhering with high resistance seals to a substrate such as perforated glass and the ability to form sheets having predominantly an ion channel or transporter of interest, a high throughput screen for determining the effect of test compounds on ion channel or transporter activity, methods for manufacture of the structure, membrane and substrate, and a method for monitoring ion channel or transporter activity in a membrane.
    Type: Grant
    Filed: May 2, 2013
    Date of Patent: June 24, 2014
    Assignee: Xention Limited
    Inventors: David Geraint Owen, Nicholas Gerard Byrne
  • Publication number: 20130288289
    Abstract: The present invention relates to a structure comprising a biological membrane and a porous or perforated substrate, a biological membrane, a substrate, a high throughput screen, methods for production of the structure membrane and substrate, and a method for screening a large number of test compounds in a short period. More particularly it relates to a structure comprising a biological membrane adhered to a porous or perforated substrate, a biological membrane capable of adhering with high resistance seals to a substrate such as perforated glass and the ability to form sheets having predominantly an ion channel or transporter of interest, a high throughput screen for determining the effect of test compounds on ion channel or transporter activity, methods for manufacture of the structure, membrane and substrate, and a method for monitoring ion channel or transporter activity in a membrane.
    Type: Application
    Filed: May 2, 2013
    Publication date: October 31, 2013
    Inventors: David Geraint Owen, Nicholas Gerard Byrne
  • Patent number: 8449825
    Abstract: The present invention relates to a structure comprising a biological membrane and a porous or perforated substrate, a biological membrane, a substrate, a high throughput screen, methods for production of the structure membrane and substrate, and a method for screening a large number of test compounds in a short period. More particularly it relates to a structure comprising a biological membrane adhered to a porous or perforated substrate, a biological membrane capable of adhering with high resistance seals to a substrate such as perforated glass and the ability to form sheets having predominantly an ion channel or transporter of interest, a high throughput screen for determining the effect of test compounds on ion channel or transporter activity, methods for manufacture of the structure, membrane and substrate, and a method for monitoring ion channel or transporter activity in a membrane.
    Type: Grant
    Filed: November 5, 2010
    Date of Patent: May 28, 2013
    Assignee: Xention Limited
    Inventors: David Geraint Owen, Nicholas Gerard Byrne
  • Publication number: 20110048939
    Abstract: The present invention relates to a structure comprising a biological membrane and a porous or perforated substrate, a biological membrane, a substrate, a high throughput screen, methods for production of the structure membrane and substrate, and a method for screening a large number of test compounds in a short period. More particularly it relates to a structure comprising a biological membrane adhered to a porous or perforated substrate, a biological membrane capable of adhering with high resistance seals to a substrate such as perforated glass and the ability to form sheets having predominantly an ion channel or transporter of interest, a high throughput screen for determining the effect of test compounds on ion channel or transporter activity, methods for manufacture of the structure, membrane and substrate, and a method for monitoring ion channel or transporter activity in a membrane.
    Type: Application
    Filed: November 5, 2010
    Publication date: March 3, 2011
    Applicant: XENTION LIMITED
    Inventors: David Geraint Owen, Nicholas Gerard Byrne
  • Patent number: 7846389
    Abstract: The present invention relates to a structure comprising a biological membrane and a porous or perforated substrate, a biological membrane, a substrate, a high throughput screen, methods for production of the structure membrane and substrate, and a method for screening a large number of test compounds in a short period. More particularly it relates to a structure comprising a biological membrane adhered to a porous or perforated substrate, a biological membrane capable of adhering with high resistance seals to a substrate such as perforated glass and the ability to form sheets having predominantly an ion channel or transporter of interest, a high throughput screen for determining the effect of test compounds on inn channel or transporter activity, methods for manufacture of the structure, membrane and substrate, and a method for monitoring ion channel or transporter activity in a membrane.
    Type: Grant
    Filed: May 20, 2005
    Date of Patent: December 7, 2010
    Assignee: Xention Limited
    Inventors: David Geraint Owen, Nicholas Gerard Byrne
  • Patent number: 7384733
    Abstract: The invention provides a novel development of the conventional patch clamp technique for measurement of whole cell electrical activity. The invention provides for one or more cell or cells to be suspended in a liquid medium at a liquid/air interface (by virtue of the effect of surface tension at the interface) whereby the cell or cells are accessible at the interface to a microstructure electrode (such as a pipette tip) to which a cell can attach to form an electrical seal, for the purpose of whole cell voltage clamp recording. According to the invention the electrode can be caused to form a high resistance electrical seal with a cell suspended in the liquid at the liquid/air interface without the need to press the cell against a solid support surface. The invention also provides apparatus for carrying out the interface patch clamp technique and control logic for operating a computer to carry out the interface patch clamp technique.
    Type: Grant
    Filed: December 6, 1999
    Date of Patent: June 10, 2008
    Assignee: Xention Discovery Limited
    Inventors: Nicholas Gerard Byrne, David Geraint Owen
  • Patent number: 6936462
    Abstract: The present invention relates to a structure comprising a biological membrane and a porous or perforated substrate, a biological membrane, a substrate, a high throughput screen, methods for production of the structure membrane and substrate, and a method for screening a large number of test compounds in a short period. More particularly it relates to a structure comprising a biological membrane adhered to a porous or perforated substrate, a biological membrane capable of adhering with high resistance seals to a substrate such as perforated glass and the ability to form sheets having predominantly an ion channel or transporter of interest, a high throughput screen for determining the effect of test compounds on ion channel or transporter activity, methods for manufacture of the structure, membrane and substrate, and a method for monitoring ion channel or transporter activity in a membrane.
    Type: Grant
    Filed: June 14, 1999
    Date of Patent: August 30, 2005
    Assignee: Xention Discovery Limited
    Inventors: David Geraint Owen, Nicholas Gerard Byrne
  • Publication number: 20030139336
    Abstract: A novel development of the conventional patch clamp technique for measurement of whole cell electrical activity provides for cells to be suspended in a liquid medium at a liquid/air interface (by virtue of the effect of surface tension at the interface) whereby cells are accessible at the interface to a microstructure electrode (such as a pipette tip (3)) to which a cell can attach to form an electrical seal, for the purpose of whole cell voltage clamp recording. The electrode forms a high resistance electrical seal with a cell suspended at the interface without the need to press the cell against a solid support surface. The step of bringing the electrode into contact with the interface is achieved not by relative movement, but by applying a differential pressure across the interface to cause the meniscus to be lowered and so to “bulge” (16) towards and into contact with the electrode.
    Type: Application
    Filed: December 13, 2002
    Publication date: July 24, 2003
    Inventors: James Henry Norwood, David Geraint Owen, Voi Piotrowski
  • Publication number: 20030129581
    Abstract: A method and apparatus for obtaining a patch-clamp recording from a cell, including providing a microchannel for axial flow of a liquid, providing at least one access port to allow radial access to the interior of the microchannel whereby liquid in the microchannel forms a meniscus at the port and produces an air/liquid interface, providing a patch-clamp pipette having a tip suitable for passing into the access port to form a high-resistance electrical seal between the tip and the cell, passing liquid carrying the cell axially along the microchannel, causing the cell to be carried to the access port, moving the patch-clamp pipette tip and the microchannel relative to each other radially to bring the tip into contact with the air/liquid interface in the access port, and applying suction to the patch-clamp to draw the cell onto the tip to form the seal.
    Type: Application
    Filed: December 6, 2002
    Publication date: July 10, 2003
    Inventors: David Geraint Owen, Andrew John Silverthorne
  • Patent number: 5965696
    Abstract: This invention concerns peptides (I) having intracellular potassium channel modulating activity comprising the amino acid sequence shown in SEQ ID No: 2:(N terminal function) (I) Met Ile Ser Ser Val Cys Val Ser Ser 1 5} Tyr Arg Gly Arg Lys Ser Gly Asn Lys 10 15 Pro Pro Ser Lys Thr Cys Leu Lys Glu Glu 20 25 (C terminal function)in which the cysteines are optionally linked via a disulphide bridge and wherein ______________________________________ Met represents L-methionine Ile represents L-isoleucine Ser represents L-serine Val represents L-valine Cys represents L-cysteine Tyr represents L-tyrosine Arg represents L-arginine Gly represents glycine Lys represents L-lysine Asn represents L-asparagine Pro represents L-proline Thr represents L-threonine Leu represents L-leucine Glu represents L-glutamic acid ______________________________________or a variant thereof,with the proviso that excluded is the 13-Lys variant (where 13-Arg is replaced by 13-Lys) in which the cysteines are not linked via a disulphide bridge
    Type: Grant
    Filed: May 26, 1995
    Date of Patent: October 12, 1999
    Assignee: John Wyeth & Brother, Ltd.
    Inventors: Roger Crossley, Albert Opalko, David Geraint Owen, Brian Robertson